Parmax Pharma Ltd

we would like to inform you that the financial statements for the period ending on September 30 2024 were duly prepared and approved at the scheduled meeting of Board of Directors held on Thursday 14th November 2024. We apologize for this delay in filing due to circumstances beyond our control.We request you to condone this delay filing as all processes and approvals were completed within the required timeline.